JavaScript seems to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.

100% Secure Online Payments

Fast & Efficient Delivery

Bulk DISCOUNTS Available

01480 839 015

All

Human Apolipoprotein C-II (Apo C2) AssayMax™ELISA Kit

Human Apolipoprotein C-II (Apo C2) AssayMax™ELISA Kit

Move your mouse over image or click to enlarge

Human Apolipoprotein C-II (Apo C2) AssayMax™ELISA Kit

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.

View Datasheet

Cat#	Size	Price	Qty	Buy
EA8012-1	96 Well Plate	£276.25

Additional Information

Property	Value or Rating
Manufacturer	Assaypro, LLC.
Product Type	AssayMax™ ELISA Kits
Samples	Serum, Cell Culture
Species	Human
Reactivity	Human
Assay Format	Sandwich ELISA
Product Size	96 Well Plate
Range	0.063-4 ug/ml
Plex Number	1
Storage	Refer to component labels for details
Entrez Gene	344
Omim	608083
UniProt	P02655
UniGene	Hs.75615
Special Notes	For Research Use Only, Not To Be Used For Diagnostic Purposes
References	* Cohen M et al. (2011) Serum Apolipoproteins C-I and C-III Are Reduced in Stomach Cancer Patients: Results from MALDI-Based Peptidome and Immuno-Based Clinical Assays. PLoS One 6(1): e14540 * Xue A et al. (2012) Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma. Br J Cancer. 107(11):1883-91 * Flood-Nichols SK et al. (2013) Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach. Molecular & Cellular Proteomics 12.1 " title=" * Cohen M et al. (2011) Serum Apolipoproteins C-I and C-III Are Reduced in Stomach Cancer Patients: Results from MALDI-Based Peptidome and Immuno-Based Clinical Assays. PLoS One 6(1): e14540 * Xue A et al. (2012) Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma. Br J Cancer. 107(11):1883-91 * Flood-Nichols SK et al. (2013) Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach. Molecular & Cellular Proteomics 12.1 " target="_blank"> * Cohen M et al. (2011) Serum Apolipoproteins C-I and C-III Are Reduced in Stomach Cancer Patients: Results from MALDI-Based Peptidome and Immuno-Based Clinical Assays. PLoS One 6(1): e14540 * Xue A et al. (2012) Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma. Br J Cancer. 107(11):1883-91 * Flood-Nichols SK et al. (2013) Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach. Molecular & Cellular Proteomics 12.1

Related Documents